Martina Verolin of Toleranzia joined us for World Orphan Drug Congress USA 2015 to present about ‘Harnessing the Power of the Immune System’ .
Download the presentation now to understand more about:
- Myasthenia Gravis (MG): an autoimmune neuromusculur disease
- Key principal protein components for the treatment of MG
- Unique breakthrough
- Myasthenia Gravis proof-of-concept studies
…and much more!
Get your copy here!
To find out more about Toleranzia’s unique breakthrough in the treatment of MG , join us at World Orphan Drug Congress USA 2016 April 20-22 in Washington, DC.